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ABSTRACT
Background and Aims Research has shown that internet interventions can be effective for dependent users of various
substances. However, less is known about the effects of these interventions on users of opioids, cocaine and amphetamines
than for other substances. We aimed to investigate the effectiveness of internet interventions in decreasing the usage of
these types of substances.Methods We conducted a systematic literature search in the databases of PubMed, PsycINFO,
Embase and the Cochrane Library to identify randomized controlled trials examining the effectiveness of internet
interventions compared with control conditions in reducing the use of opioids, cocaine and amphetamines. No setting
restrictions were applied. The risk of bias of the included studies was examined according to the Cochrane Risk of Bias
assessment tool. The primary outcome was substance use reduction assessed through toxicology screening, self-report
or both at post-treatment and at the follow-up assessment. Results Seventeen studies with 2836 adult illicit substance
users were included. The risk of bias varied across the included studies. Internet interventions decreased signiﬁcantly
opioid [four studies, n = 606, g = 0.36; 95% conﬁdence interval (CI) = 0.20–0.53, P < 0.001] and any illicit substance
use (nine studies, n=1749, g = 0.35; 95%CI = 0.24–0.45, P< 0.001) at post-treatment. Conversely, the effect of internet
intervention for stimulant users was small and non-signiﬁcant (four studies, n = 481, P = 0.164). Overall, internet
interventions decreased substance signiﬁcantly use at post-treatment (17 studies, n = 2836, g = 0.31; 95%
CI = 0.23–0.39, P < 0.001) and at the follow-up assessments (nine studies, n = 1906, g = 0.22; 95% CI = 0.07–0.37;
P = 0.003). Conclusions Internet interventions demonstrate small but signiﬁcant effects in decreasing substance use
among various target populations at post-treatment and at the follow-up assessment. However, given the small number
of available studies for certain substances, the ﬁndings should be interpreted with caution.
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INTRODUCTION
Illicit substance use is a major health issue associated with
serious physical, psychological and social harm [1].
Approximately 187000 of 27million illicit substance users
die annually due to drug-related deaths [2]. Causes of
death include drug overdoses and delayed or chronic
drug-related medical consequences, including infections,
fatal liver diseases, respiratory and cardiovascular diseases.
The most widely used illicit substances are cannabis
(although recently decriminalized/legalized in various
countries) opioids, amphetamines and cocaine, of which
the global use estimates are 3.9, 0.7, 0.7 and 0.4%,
respectively [2]. Moreover, previous ﬁndings indicate that
regardless of the primary substance, illicit substance abuse
and dependence, referred to currently as substance use
disorder, accounts for approximately 20 million disability-
adjusted life years (DALYs) lost every year world-wide [3].
This is a substantial amount given that, for example, other
serious disorders, such as dementia, account for
approximately only 11 million DALYs [4]. Consequently,
illicit substance use imposes a signiﬁcant societal and
economic burden [5–7].
Pharmacological interventions are not yet available for
amphetamine and cocaine users [8]. Moreover, the
literature indicates mixed results for opioid users [9].
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However, several meta-analyses have shown that
psychosocial and behavioural treatments are effective in
reducing illicit substance use [10–15]. Unfortunately, only
20% of individuals with a substance use disorder utilize
mental health and addiction services [16]. This
phenomenon can be attributed to a variety of reasons, such
as lack of availability of treatment services, available but
overcrowded programmes, time conﬂicts, ﬁnancial
barriers, fear of stigma and the requirement of abstinence
as a goal [17–19]. Internet interventions might be a novel
approach to overcoming these obstacles [20] by increasing
the number of people receiving standardized evidence-
based treatments, minimizing therapists’ time and
decreasing treatment costs [21].
Two distinct internet-based approaches are applied
commonly in the substance use literature, unguided
stand-alone internet interventions and internet
interventions as an add-on to treatment as usual (TAU).
These approaches offer distinct advantages: unguided
stand-alone internet interventions are capable of
supporting numerous substance users simultaneously
with a low threshold for accessibility [22–25]. Conversely,
add-on internet interventions that are combined with
face-to-face support are more intensive treatment in which
the support of a mental health professional and the high
level of convenience and ﬂexibility of internet interventions
are combined. Both approaches have demonstrated
encouraging effects for nicotine, alcohol and cannabis
users in previous meta-analyses [22,23,26].
However, to the best of our knowledge, no previous
meta-analysis has examined the effectiveness of internet
interventions regarding substance use reduction in users
of opioids, cocaine, amphetamines and any illicit
substances [27]. The present meta-analysis aimed to
examine to what extent internet interventions are effective
in reducing the use of opioids, cocaine, amphetamines and
any illicit substances in adults compared to controls. By the
term ‘any illicit substance users’, we refer to individuals
who use at least one illicit substance and are included in
transdiagnostic interventions targeting various substances
at once.
METHODS
Identiﬁcation of studies
We conducted a systematic literature search up to
January 2016 on the following databases: PubMed,
PsycINFO, EMBASE and Cochrane Central Register
of Controlled Trials. We used various combinations
of key and index terms covering the concepts of
substances (drug abuse, addiction, drug dependence,
polydrug, heroin, cocaine, crack, opioid, benzodiazepine,
ecstasy, amphetamine, methamphetamine) and internet
interventions (internet, web, online, computer, mobile)
(the full search string for PubMed is given in Supporting
information, Appendix S1). Furthermore, we applied a
ﬁlter for randomized controlled trials (RCTs) in these
databases. We conducted additional searches by
checking references of the included studies [28]. Our
initial selection was based on titles and abstracts.
Subsequently, full texts of studies possibly meeting
inclusion criteria were retrieved and evaluated. No
language restrictions were applied. All searches and
screenings were performed independently by two of the
authors (N.B.) and (E.K.), and disagreements were
resolved through discussion. The identiﬁed interventions
were either web-based or computerized; however, for the
sake of clarity, we will refer to the included interventions
as ‘internet interventions’.
Eligibility criteria
We included RCTs that compared internet or computerized
interventions with active [e.g. TAU, motivational
interviewing (MI), brief intervention (BI),
psychoeducation] or non-active (e.g. waiting-list,
assessment-only) control conditions. The RCTs had to focus
upon adult current users of illicit substances, such as
cocaine, amphetamines, opioids or any illicit substances.
By ‘users of any illicit substances’, we describe individuals
who use at least one illicit substance. Transdiagnostic
interventions, targeting those users of any illicit
substances, screen for the most common substances,
including opioids, cocaine, stimulants, cannabis and
alcohol. Furthermore, studies had to include a
measurement of substance use of the participants’ at
post-test, measured through self-report, toxicology
screening or both. No distinction was made between use
and abuse or dependence. Studies that did not focus on
protocolized interventions but on the internet as a
communication medium (e.g. by e-mail, chat or video
consultation) were excluded (see Fig. 1).
Quality assessment
The validity of the included studies was assessed
according to the criteria of the Cochrane risk of bias
assessment tool [29]. We tested (1) adequacy of
allocation sequence generation, (2) concealment of the
allocation to the particular conditions, (3) blinding of
the participants and personnel, (4) blinding of the
outcome assessors, (5) appropriate handling of
incomplete outcome data by applying an intention-to-
treat design, (6) selective outcome reporting, and ﬁnally
(7) other potential threats to validity, such as early
cessation of the trial or extreme baseline imbalances.
Two authors (N.B. and E.K.) assessed the risk of bias,
and disagreements were resolved by discussion.
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Data extraction
We extracted a set of outcome variables measuring the
same construct; namely, substance use reduction. This
practice enabled us to summarize available ﬁndings
adequately. In case the studies reported more than one
relevant outcome, we aggregated the means of these
variables to yield an overall mean effect size for each
study. These variables included: (a) mean maximum
number of days or weeks abstinent throughout
treatment, (b) number of positive urine samples, (c)
consumption within previous weeks or months and (d)
post-treatment and follow-up scores based on self-report
scales. Data were extracted for both post-treatment and
the longest follow-up (6 months post-randomization
and beyond) outcomes available, and these were
analysed separately. Additional aspects of the studies
were coded, including participant characteristics
(primary substance, recruitment method, setting,
medication); intervention characteristics (type of
intervention, format, duration, type of assessment,
inclusion and exclusion criteria, number of sessions,
attrition); control characteristics; length of the follow-
up period; and the country in which the trial was
carried out (see Table 1). In cases where eligible studies
did not report the necessary data to conduct
quantitative analyses, we attempted to contact the ﬁrst
author to gain the necessary data [30–32]. In the event
of no reply, the studies were not included in the present
systematic review [30].
Meta-analyses
We chose to calculate Hedges’ g as the effect size
indicating the difference for each comparison between
an internet intervention and a control condition. The
effect size for small sample bias was corrected according
to the procedures suggested by Hedges & Olkin [33].
Given that there is no gold standard of how to report
results in the substance use literature [34], we expected
to encounter a great variety of outcome reporting styles.
The computer program Comprehensive Meta-Analysis
(CMA, version 3.3.070) was used for all analyses. Effect
sizes were calculated by (a) subtracting the average post-
treatment score of the intervention group from the
mean score of the control group and dividing the result
by the pooled standard deviations of the two groups
[35], (b) transforming test statistics (e.g. t, F, r) into
the standardized mean difference [36], (c) transforming
odds ratios into the standardized mean difference [37];
and (d) transforming medians and interquartile range
into means and standard deviations [38]. Effect sizes of
approximately 0.8 can be considered large, 0.5 as
moderate and 0.2 small [35]. When studies included
two or more intervention conditions, we split the control
condition into two or more groups and divided the
Figure 1 Flowchart of inclusion of studies
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sample size by that number [39]. Consequently,
intervention groups were compared separately with the
relevant control conditions. If the author reported
results separately for certain subgroups (e.g. gender or
occupational status), the subgroups were combined and
compared as one group with the relevant control
condition [39,40]. As we expected heterogeneity among
the studies, we decided to calculate mean effect sizes
using a random-effects model. This model assumes that
the included studies were drawn from populations of
studies that differed systematically from one another
[41]. We calculated the I2 statistic as an indicator of
heterogeneity in percentages to test the homogeneity of
effect sizes. A value of 0% suggests no observed
heterogeneity, while 25, 50 and 75% suggest low,
moderate and high heterogeneity, respectively.
Furthermore, we estimated 95% conﬁdence intervals
(CI) around I2 [42], using the non-central χ2-based
approach within the HETEROGI module for Stata [43].
Publication bias was tested by inspecting the funnel plot
visually. Furthermore, Egger’s linear regression test of
the intercept was applied to examine if the bias captured
by the funnel plot was signiﬁcant [44]. We also used
Duval & Tweedie’s trim-and-ﬁll procedure [45], which
produces an imputed estimate of the effect size
accounting for missing studies. We investigated the
presence of outliers by examining whether effect sizes and
95% CI of each study overlapped with the 95% CI of the
pooled effect size; if an outlying effect size was identiﬁed,
it was excluded to examine the extent to which it affects
the results. Factors that, according to the literature, may
have led to heterogeneity and differences between the
results of individual studies were investigated through
subgroup analyses. Various subgroup analyses were
conducted (see Table 3, Supporting information, Appendix
S2), according to the mixed-effects model [41]. In this
model, studies within subgroups are pooled with the
random-effects model, whereas analyses for signiﬁcant
differences between subgroups are conducted with the
ﬁxed-effects model. Given the similar behavioural and
physiological effects of cocaine and amphetamines [46]
and the low number of available studies for each substance,
we decided to combine the RCTs targeting these
populations in the subgroup analyses creating a combined
group; namely, stimulant users. Finally, we conducted
three univariable meta-regression analyses to assess the
association of the effect size of the internet interventions
on substance use reduction (as reported at post-test) with
(a) the duration, (b) the number of sessions and (c) the risk
of bias of the assessed studies. In a meta-regression
analysis, the outcome variable is being predicted according
to explanatory variables. The resulting regression
coefﬁcient describes how the outcome variable changes
with a unit increase in the explanatory variable [47].
Power calculation
As we expected to ﬁnd only a limited number of studies for
each primary substance, we conducted a power
calculation to investigate the necessary amount of studies
that would have to be included to have sufﬁcient statistical
power to determine relevant post-treatment and follow-up
effects [41]. Assuming a small effect size of g = 0.30, with a
moderate level of between-study variance (τ2), a statistical
power of 0.80 and an alpha of 0.05, we estimated that ﬁve
studies with a mean of 60 participants per condition would
be required, or 10 studies with 30 participants per
condition. Alternatively, we would need 10 studies with
17 participants per condition to detect an effect size of
g = 0.4, or ﬁve studies with 34 participants per condition.
RESULTS
Selection and inclusion of studies
From the 3057 abstracts (2138 after removal of
duplicates), we retrieved 580 full-text papers for possible
inclusion in the present systematic review, 563 of which
were excluded because they did not meet the inclusion
criteria. The ﬂowchart describing the inclusion process is
presented in Fig. 1. We included in the analysis a total of
17 individual studies with 18 individual comparisons that
met all the inclusion criteria.
Characteristics of included studies
Selected characteristics of the included studies are
presented in Table 1. In the present meta-analysis, 17
studies with a total of 2836 participants were included
(n = 1461 in the intervention condition; n = 1375 in the
control condition). Eight studies included participants
based on a DSM-IV diagnosis, six studies included
individuals according to a cut-off score based on self-
reported substance use, two studies included individuals
with an elevated substance score on the Alcohol, Smoking
and Substance Involvement Screening Test (ASSIST) [48]
and one study included participants who scoredmore than
zero at the Drug Use Disorders Identiﬁcation Test (DUDIT)
[49]—indicating at least minimal illicit substance use.
Three target populations were addressed in these trials;
namely, opioid users (n = 4), stimulant users (n = 4) and
users of any illicit substances (n = 9). By ‘users of any illicit
substances’, we describe individuals who use at least one
illicit substance. RCTs, which target users of any illicit
substances, screen for the most common substances,
including opioids, cocaine, stimulants, cannabis and
alcohol, and provide transdiagnostic interventions. The
majority of the studies included recruited the participants
from a clinical setting (out-patient facility n = 5, hospital
n = 4, residential centre n = 1), whereas the remaining
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seven studies recruited their participants from the
community. Gender was distributed equally between the
intervention and control conditions. The overall study
attrition varied substantially, ranging from 8 to 89%. Five
of the included studies provided medication to the patients
[32,39,50–52], three speciﬁcally excluded patients
receiving medication [31,53,54], and the remaining
studies did not report the proportion of patients on
medication [40,55–62]. Nine trials applied an add-on
intervention, whereas eight trials applied an unguided
standalone intervention. Three of the nine studies that
included users of any illicit substances compared unguided
standalone internet interventions with non-active
controls, three compared add-on interventions with TAU
only and three compared unguided standalone internet
interventions with other types of active controls (MI, BI,
psychoeducation). The four opioid primary substance
studies compared add-on interventions with TAU only. Of
the four studies on stimulant users, two compared add-on
interventions with TAU only and two compared an
unguided standalone intervention with a non-active
control.
The interventions applied varied according to the target
population (interventions were deﬁned as described in
Table 2). The community reinforcement approach (CRA)
was applied for opioid users, whereas cognitive behaviour
therapy (CBT) was the prevailing approach for stimulant
users. Internet interventions targeting users of any illicit
substances varied considerably in terms of treatment
approach and number of sessions, with MI being the
dominant approach. Of the 17 studies in total, some studies
employed more than one type of assessment. Speciﬁcally,
12 employed measures based on toxicology screenings,
such as urine or hair analyses, and 11 studies employed
self-report measures, such as the ASSIST, the DUDIT and
through online questionnaires that measured number of
days using. The studies were carried out in ﬁve different
countries (Australia n = 1, Brazil n = 1, Sweden n = 1,
Switzerland n = 1, and the United States n = 13).
Quality assessment
The methodological quality of the studies varied (see
Supporting information, Appendix S3). Fifteen of the 17
studies reported an adequate sequence generation. Six
studies described adequate allocation concealment. None
of the studies blinded the participants and personnel and
were hence considered as at high risk of bias. Thirteen of
the studies employed toxicology screenings to measure
substance use, thus blinding of the outcome assessment
was considered as at low risk of bias, while four studies
employed self-reporting scales, thus blinding of the
outcome assessment was considered as at high risk of bias
for these studies. Incomplete outcome data were handled
correctly in 13 studies. All the studies reported all expected
outcomes, and ﬁnally, none of the included studies had
other potential threats to validity. Three studies met six of
the seven quality criteria, 10met ﬁve criteria, two met four
criteria and the remaining two studies met only three
criteria. However, only three of the included RCTs provided
their protocol online for evaluation [31,53,54]. As a result,
it is impossible to investigate protocol violations, which
have been shown to be a serious threat to the validity of
the study results [63].
The overall effect of internet interventions on illicit
substance users
Because the number of studies per primary substance was
small, we opted to pool the studies together to increase the
statistical power and consequently enable the investigation
of study characteristics in subgroup analyses. There was a
small but signiﬁcant overall effect of internet interventions
on substance use reduction when all experimental
conditions (n = 18) were compared with the control
conditions at post-treatment assessment. Heterogeneity
was moderate. A visual inspection of the forest plot
indicated two possible outliers [57,58], in which the effect
size did not overlap with the 95% CI of the pooled effect size.
Therefore, we excluded the possible outliers. This exclusion
resulted in a marginal increase of the effect size in favour of
internet interventions (see Fig. 2). A post-hoc power
calculation indicated that our set of studies had sufﬁcient
statistical power to detect an effect size of 0.16 on the basis
of the random-effects model (with a low level of between-
study variance, τ2 = 0, a statistical power of 0.80 and a
signiﬁcance level of P< 0.05). Inspection of the funnel plot
and Duval & Tweedie’s trim-and-ﬁll procedure did not
indicate publication bias. Moreover, nine studies reported
follow-up outcomes of internet interventions against
control conditions, six of whichwere studies including users
of any illicit substances and three included stimulant users.
At the follow-up (6–12 months), internet interventions
(n = 9) outperformed control groups on substance use
reduction for illicit substance users. The effect size was small
but signiﬁcant (n = 1906, g = 0.22; 95% CI = 0.07–0.37;
P = 0.003). A post-hoc power calculation indicated that
our set of studies for follow-up effects had sufﬁcient
statistical power to detect an effect size of 0.22 on the basis
of the random-effects model (with a low level of between-
study variance, τ2 = 0.001, a statistical power of 0.80 and
a signiﬁcance level of P < 0.05) (Fig. 2 and Table 3).
Substance-speciﬁc results of internet interventions
The effects of internet interventions on substance use
reduction were similar for opioid users (n = 606,
g = 0.36; 95% CI = 0.20–0.53, P < 0.001) and users of
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any illicit substances, indicating a small but signiﬁcant
effect. A visual inspection of the forest plot indicated two
possible outliers [57,58], in which the effect size did not
overlap with the 95% CI of the pooled effect size. Therefore,
we excluded the possible outliers. This exclusion resulted in
a marginal increase of the effect size for users of any illicit
substances in favour of internet interventions (n = 1749,
g = 0.35; 95% CI = 0.24–0.45, P < 0.001; I2 = 0; 95%
CL = 0–71, P = .750). Conversely, the effect of internet
intervention on stimulant use reduction was small and
non-signiﬁcant when compared to the control conditions
(n = 481, P = 0.164) (Fig. 2 and Table 3).
Table 2 Deﬁnitions of internet interventions for illicit substance users.
Conditions Deﬁnition Nst Np
Treatment as usual (TAU) TAU may vary to some extend depending on the facility; however, the majority of the
facilities employ individual and group counselling that focuses largely on patients’
compliance with programme rules and rehabilitation. The counsellor might focus on
assisting patients with current problems (e.g. employment, recent arrests, illness, housing)
and current treatment progress (attendance, urine test results). Patients often also receive
HIV educational materials [66,67]
9 1366
Community reinforcement
approach (CRA)
CRA is a comprehensive behavioural programme that assists individuals to discover and
adopt the fact that a healthy life-style is more rewarding than a deleterious
Life-style ﬁlled with substance use. Consequently, it employs social, recreational, vocational
and familial incentives to change the environment of substance-misusing individuals [68]
6 569
Contingency management
(CM)
In CM patients’ behaviour is reinforced by rewards according to the level to which they
adhere in their treatment plan (e.g. negative urine screenings). Incentives usually include
vouchers with monetary value that can be exchanged for goods and services. The value of
these incentives typically increase gradually after each negative urine screening [69]
5 567
Motivational interviewing
(MI)
MI is a client-centred approach that seeks to elicit and reinforce the clients motivation for
change. MI assumes that support from a therapist in the context of an egalitarian
relationship enhances the likelihood of positive behaviour change, while a directive
approach might inhibit such change. However, fully self-guided internet interventions are
restricted when delivering certain components of MI, such as providing a therapeutic
rapport and might, therefore, not be appropriate in all cases [70]. Key components of MI
include acceptance, empathy, collaborative partnership, compassion, direction and
evocation of client motivation [71]
5 470
Cognitive behaviour therapy
(CBT)
CBT targets individual and social triggers for relapse via functional analysis of substance use
behaviour and coping skills training to support the individual to abandon habits associated
with substance use by substituting them with healthier alternative habits [72]
4 261
Brief intervention (BI) BIs are concise, solution focused interventions that focus on speciﬁc measurable outcomes.
They rely upon the assumption that guidance from experts can promote change and provide
personalized feedback according to general practitioners or patient population data [73]
1 360
Cognitive rehabilitation (CR) The rationale for this approach lies in the fact that previous ﬁndings have shown that
substance users often demonstrate various deﬁcits in cognitive skills. Thus, addressing these
critical aspects of cognitive function might be a novel strategy for increasing treatment
effects and decreasing substance use. CR interventions consist of various exercises intended
to enhance cognitive skills such as problem-solving, attention, memory and abstract
reasoning [74]
1 80
Internet interventions Internet interventions are standardized interventions that are delivered via the internet. Due
to this delivery method, a wide variety of advantages become possible, such as the
widespread dissemination of information to individuals who face various barriers including
economical ones, stigma, transportation or other obstacles that might limit access to
traditional treatments [75]
6 862
Computerized interventions Computer-delivered programs are standardized interventions that are delivered via a
software program on a computer. These interventions often made use of CD rom disks and
preceded internet interventions. This type of delivery method provides the advantage to the
individual of being able to access the intervention ofﬂine, which might be an important
aspect in cases where the internet is not accessible or available. However, this advantage
comes with the drawback of not being as interconnected compared with internet
interventions, which limits dissemination and collection of data [76].
11 705
Nst = number of studies; Np = total number of participants.
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Subgroup analyses
We conducted a series of subgroup analyses (see Table 3,
Supporting information, Appendix S2). These analyses
indicated that add-on interventions were more effective
compared to unguided standalone interventions and the
type of assessment; speciﬁcally, toxicology screenings were
associated with higher effect sizes compared to self-report.
Interventions delivered in an out-patient clinic via
computer were signiﬁcantly more effective compared to
interventions delivered via computer at a university and
via the internet at home. Finally, the type of eligibility
screening also affected the outcomes; speciﬁcally, DSM-IV
diagnoseswere associatedwith higher effect sizes compared
to cut-off scores on self-reported substance use (Table 3).
Meta-regression analyses
The meta-regression analyses did not reveal signiﬁcant
associations between the effect size of internet
interventions on substance use reduction and (a) duration
(slope: 0.002; 95% CI = 0.007 to 0.012, P = 0.652), (b)
number of sessions (slope: 0.003; 95% CI = 0.003 to
0.008, P = 0.338) and (c) risk of bias (slope: 0.063;
95% CI = 0.187 to 0.062, P = 0.326).
DISCUSSION
The present systematic review was the ﬁrst, to our
knowledge, to examine the effectiveness of internet
interventions regarding substance use reduction of opioids,
stimulants and any illicit substances at both post-treatment
and at the follow-up. We found a small but signiﬁcant
overall effect size of internet interventions for the reduction
of illicit substance use at post-treatment (g = 0.30) and at
the follow-up assessment (g = 0.22). Speciﬁcally, internet
interventions decreased opioid use (g= 0.36) and any illicit
substance use signiﬁcantly (g = 0.32), but did not reduce
stimulant use signiﬁcantly. These ﬁndings are in line with
the broader literature of internet interventions on nicotine,
alcohol and cannabis use reduction that indicate small but
signiﬁcant effects [22,23,26].
Our subgroup analyses displayed varying effects,
depending on certain characteristics of the trials; namely,
format of the intervention, type of the assessment,
screening and setting. Speciﬁcally, (a) add-on interventions
displayed higher effects compared to unguided standalone
interventions, (b) studies which applied toxicology
screenings as outcome measure were associated with
higher effect sizes compared to studies that applied self-
report measures, (c) DSM-IV diagnoses were associated
with higher effect sizes compared to cut-off scores on self-
reported substance use, and ﬁnally (d) studies that
conducted the intervention in clinical out-patient clinics
showed higher effect sizes compared to other settings.
Limitations
We were not able to extract data from all eligible studies,
because one study did not report outcome data [27]. This
study found no signiﬁcant effects in substance use when
adding an add-on internet intervention to the TAU setting.
Moreover, it should be taken into account that certain
characteristics of the trials (add-on intervention, toxicology
Figure 2 Forest plot of intervention effects at post-treatment assessments
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screening, out-patient clinic) are associated predominantly
with intensive treatments that were compared with TAU,
while other characteristics (e.g. unguided standalone
interventions, self-report assessments, home setting) were
associated predominantly with less intensive interventions
and compared primarily (except for three [40,58,63]
studies) with inactive interventions, such as assessment-
only and waiting-list. For this reason, we suggest that the
unexpected ﬁnding of toxicology screenings and DSM
diagnoses being associated with higher effect sizes might
be the fact that they are applied in studies with intensive
treatments that target severe users and have higher
chances of yielding high effect sizes compared to studies
with less intensive treatments that target less severe users.
Another explanation might be that a study requiring
toxicology screenings might lead to selection bias by
recruiting more adherent patients. Therefore, these
ﬁndings should be considered with caution. Moreover, ﬁve
of the included studies applied completers’ only analyses
[31,39,50,56,58], which might have induced
heterogeneity in our ﬁndings, especially considering the
high attrition of certain studies. Also, we experienced some
difﬁculty in assessing the inﬂuence medication might have
had on the effect sizes, as only a minority of studies
speciﬁcally excluded patients who were on medication
and the majority of the studies did not report the
proportion of patients being on medication. Finally, the
small number of available studies for certain substances
restricted our ability to reach solid conclusions about these
populations. Additionally, psychiatric comorbidity was not
examined by the included trials. Such comorbidities might
inﬂuence the adherence and the efﬁcacy of the internet
Table 3 Subgroup analyses of associations between effect sizes and study characteristics (Hedges’s g).a
Ncomp g 95% CI I2 95% CI Pb
All studies 18 0.30 0.19 to 0.41*** 50 13–71
2 possible outliers removedc 16 0.31 0.23 to 0.39*** 0 0–52
Primary substance Anyd 9 0.32 0.15 to 0.49*** 69 38–85 0.146
Opioids 5 0.36 0.20 to 0.53*** 0 0–85
Stimulants 4 0.13 –0.05 to 0.31 0 0–85
Subgroup analyses (n = 18)
Control groupe Active 13 0.31 0.16 to 0.46*** 62 31–79 0.978
Non-active 5 0.31 0.17 to 0.45*** 0 0–79
Type CRA + CM 6 0.39 0.26 to 0.52*** 0 0–75 0.382
MI 5 0.30 0.16 to 0.44*** 0 0–79
CBT 4 0.19 0.02 to 0.35 17 0–87
Other 3 0.34 –0.18 to 0.85 90 74–96
Format Add-on 10 0.41 0.30 to 0.52*** 12 0–54 0.011
Standalone 8 0.17 0.03 to 32* 43 0–75
Type of assessment Tox. screening 12 0.42 0.32 to 0.52*** 0 0–58 0.016
Self-report 11 0.26 0.05 to 0.42* 71 46–84
Screening DSM-IV 9 0.42 0.27 to 0.56*** 22 0–63 0.048
Cut-off scores 9 0.21 0.07 to 0.36** 55 4–79
Medication Yes 6 0.34 0.19 to 0.48*** 0 0–75 0.774
No 3 0.22 –0.06 to 0.50 67 0–91
NR 9 0.30 0.11 to 0.50** 67 34–84
Analyses ITT analyses 13 0.31 0.20 to 0.42*** 36 0–67 0.883
Comp. analyses 5 0.33 0.04 to 0.63* 69 20–88
Recruitment Clinical 10 0.34 0.18 to 0.49*** 63 28–82 0.341
Community 8 0.23 0.01–0.37** 11 0–71
Setting Computer, out-patient clinic 9 0.36 0.26 to .47*** 0 0–65 0.002
Computer, hospital 4 0.23 –0.44 to 0.50 71 19–90
Internet, home 3 0.11 –0.07 to 0.29 0 0–90
Computer, university 1 0.12 –0.33 to 0.56 0 NA
Computer, residential centre 1 0.82 0–50 to 1.14*** 0 NA
Female-only studies Yes 3 0.37 0.20 to 0.55*** 0 0–90 0.448
No 15 0.29 0.16 to 0.42*** 57 23–76
BI = brief intervention; CET = cognitive enhancement therapy; Comp. = completers; EDUC = psychoeducation; ITT = intention-to-treat; MI = motivational
interviewing; NA = not applicable; Ncomp = number of comparisons; NR = not reported; PA = positive affect; TAU = treatment as usual; Tox. = toxicology;
WLC = waiting-list control. aAccording to the random-effects model; bthe P-values in this column indicate if the difference between the effect sizes in the
subgroups is signiﬁcant; CI = conﬁdence interval (*P ≤ 0.05; **P< 0.01; ***P ≤ 0.001); c[57,58]. dBy the term ‘any illicit substances’we describe individuals
who use at least one illicit substance and are included in transdiagnostic interventions targeting various substances at once. eActive controls include: TAU,MI,
BI, EDUC; inactive controls include: WLC, add-on.
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interventions. Previous research has shown that
transdiagnostic interventions for substance users with
comorbid mental disorders are more effective [63] and
have higher adherence rates [64] compared to separate
treatment plans for individual disorders.
Summarizing the empirical literature on the
effectiveness of internet interventions for substance users
presented several challenges. The utilized outcomes to
determine superiority of a condition varied substantially,
and although this variation of outcomes has been noted
by previous studies [11,12,64] little effort has been taken
place to overcome this challenge. Therefore, we suggest
that future studies should approach this issue to further
improve the comparability of outcome ﬁndings.
Furthermore, the relatively high rate of attrition might be
a serious restriction. This is especially true for unguided
standalone interventions and is often considered a serious
threat to the integrity of the study results [65]. Therefore,
further research should investigate possible predictors to
prevent attrition.
CONCLUSION
Although more research is necessary to assess the
effectiveness of internet interventions in illicit substance
users, this method of treatment delivery seems to be a
promising solution for achieving substance use reduction
in these target populations.
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